Italian Clinical Study Demonstrates Nephros' Mid-Dilution HDF Therapy As Optimal Treatment for Patients with Limited (PR Newswire via Yahoo! Finance)
Nephros, Inc. , announced today the results of a clinical study conducted at the Maggiore Hospital in Lodi, Italy, by Jean Louis Renaux, PhD, Director of Scientific Affairs -- Bellco SPA.

Novartis to set up R&D pipeline, launch new product (PharmaBiz)
Novartis has unveiled new data on its promising pipeline amid plans for multiple new product approvals and launches over the next two years.